ロード中...
High expression of interleukin-enhancer binding factor 3 predicts poor prognosis in patients with lung adenocarcinoma
Interleukin-enhancer binding factor 3 (ILF3) is a double-stranded RNA-binding protein that has been reported to contribute to the occurrence and progression of various malignant tumors. The aim of the present study was to evaluate the prognostic value of ILF3 and to apply this knowledge to avoid exc...
保存先:
| 出版年: | Oncol Lett |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
D.A. Spandidos
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7039148/ https://ncbi.nlm.nih.gov/pubmed/32194712 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2020.11330 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|